小林製薬の業績推移
(単位:百万円)
|
売上高 |
営業利益 |
経常利益 |
純利益 |
売上原価 |
売上総利益 |
株主資本 |
総負債 |
総資産 |
現金及び現金同等物 |
流動市場性有価証券 |
流動資産 |
流動負債 |
利益剰余金 |
営業利益率 |
経常利益率 |
当期利益率 |
自己資本比率 |
営業キャッシュフロー |
投資キャッシュフロー |
財務キャッシュフロー |
営業キャッシュフローマージン |
フリーキャッシュフロー |
ROE |
ROA |
一株あたり利益 |
希薄化後一株あたり利益 |
従業員数 |
2023年12月
|
173,455
|
25,780
|
27,330
|
20,338
|
77,079
|
96,376
|
204,816
|
62,657
|
267,473
|
71,536
|
|
158,331
|
56,111
|
205,681
|
14.86%
|
15.76%
|
11.73%
|
76.57%
|
18,360
|
-19,576
|
-19,463
|
10.58%
|
-1,216
|
10.1%
|
7.77%
|
0.00026816
|
0.00026816
|
3534人
|
2022年12月
|
166,258
|
26,669
|
28,281
|
20,022
|
73,927
|
92,331
|
197,900
|
57,927
|
255,827
|
96,233
|
|
172,892
|
51,809
|
194,285
|
16.04%
|
17.01%
|
12.04%
|
77.36%
|
31,914
|
-14,312
|
-20,759
|
19.2%
|
17,602
|
10.18%
|
7.88%
|
0.00025963
|
0.00025959
|
3495人
|
2021年12月
|
155,252
|
26,065
|
28,015
|
19,715
|
66,478
|
88,774
|
195,600
|
56,954
|
252,554
|
95,024
|
|
181,889
|
50,703
|
200,534
|
16.79%
|
18.04%
|
12.7%
|
77.45%
|
22,419
|
7,991
|
-10,377
|
14.44%
|
30,410
|
10.43%
|
8.03%
|
0.00025236
|
0.00025236
|
3451人
|
2020年12月
|
150,514
|
25,943
|
27,726
|
19,205
|
65,248
|
85,266
|
182,583
|
55,783
|
238,366
|
78,253
|
|
164,225
|
50,107
|
187,071
|
17.24%
|
18.42%
|
12.76%
|
76.6%
|
23,986
|
-12,656
|
-6,019
|
15.94%
|
11,330
|
10.81%
|
8.14%
|
0.00024571
|
0.00024571
|
3473人
|
2019年12月
|
158,340
|
25,658
|
27,851
|
19,139
|
67,364
|
90,976
|
172,657
|
61,075
|
233,732
|
75,580
|
|
163,046
|
53,767
|
173,650
|
16.2%
|
17.59%
|
12.09%
|
73.87%
|
20,089
|
-5,072
|
-14,581
|
12.69%
|
15,017
|
11.29%
|
8.24%
|
0.00024408
|
0.00024408
|
3435人
|
2018年12月
|
157,370
|
26,289
|
27,374
|
18,023
|
64,359
|
93,011
|
166,249
|
64,740
|
230,989
|
74,456
|
|
151,824
|
55,053
|
159,857
|
16.71%
|
17.39%
|
11.45%
|
71.97%
|
20,007
|
-8,062
|
-4,285
|
12.71%
|
11,945
|
11.26%
|
8.01%
|
0.00022805
|
0.00022795
|
3271人
|
2017年12月
|
147,903
|
22,925
|
24,191
|
15,863
|
61,238
|
86,665
|
153,811
|
65,020
|
218,831
|
64,990
|
|
142,346
|
54,274
|
146,758
|
15.5%
|
16.36%
|
10.73%
|
70.29%
|
22,350
|
7,039
|
-9,162
|
15.11%
|
29,389
|
10.68%
|
7.55%
|
0.00020131
|
0.00020103
|
3033人
|
2016年12月
|
113,969
|
17,409
|
19,499
|
14,257
|
48,638
|
65,331
|
143,320
|
57,914
|
201,234
|
58,173
|
|
128,646
|
46,975
|
147,901
|
15.28%
|
17.11%
|
12.51%
|
71.22%
|
16,097
|
-519
|
-11,922
|
14.12%
|
15,578
|
9.99%
|
7.31%
|
0.00017912
|
0.00017886
|
2994人
|
2016年3月
|
137,211
|
18,260
|
17,949
|
13,466
|
57,518
|
79,693
|
142,023
|
46,974
|
188,997
|
25,428
|
|
|
|
|
13.31%
|
13.08%
|
9.81%
|
75.15%
|
14,329
|
-10,932
|
-10,199
|
10.44%
|
3,397
|
9.56%
|
7.18%
|
0.00016556
|
0.0001653
|
2804人
|
2015年3月
|
128,344
|
17,917
|
18,843
|
12,448
|
54,718
|
73,626
|
139,611
|
46,720
|
186,331
|
58,449
|
|
115,990
|
35,890
|
127,858
|
13.96%
|
14.68%
|
9.7%
|
74.93%
|
15,445
|
-4,540
|
-5,155
|
12.03%
|
10,905
|
9.34%
|
6.97%
|
0.00030546
|
0.00030546
|
2576人
|
2014年3月
|
127,293
|
18,122
|
18,769
|
12,307
|
54,193
|
73,100
|
126,953
|
43,966
|
170,919
|
51,748
|
|
105,614
|
34,216
|
118,731
|
14.24%
|
14.74%
|
9.67%
|
74.28%
|
13,513
|
-6,959
|
-3,809
|
10.62%
|
6,554
|
10.18%
|
7.5%
|
0.00030055
|
0.00030055
|
2364人
|
2013年3月
|
121,532
|
16,903
|
18,677
|
12,176
|
51,732
|
69,800
|
114,872
|
42,234
|
157,106
|
45,862
|
|
94,353
|
34,477
|
109,946
|
13.91%
|
15.37%
|
10.02%
|
73.12%
|
9,242
|
-26,605
|
-3,729
|
7.6%
|
-17,363
|
11.24%
|
7.98%
|
0.00029737
|
0.00029737
|
2204人
|
2012年3月
|
131,166
|
|
20,092
|
11,726
|
|
|
101,879
|
46,011
|
147,890
|
42,835
|
|
|
|
|
0.0%
|
15.32%
|
8.94%
|
68.89%
|
17,250
|
-2,929
|
-3,292
|
13.15%
|
14,321
|
|
|
0.00028636
|
0.00028636
|
2414人
|
2011年3月
|
130,824
|
|
19,010
|
9,335
|
|
|
|
|
|
|
|
|
|
|
0.0%
|
14.53%
|
7.14%
|
|
|
|
|
|
|
|
|
0.00022798
|
0.00022798
|
2390人
|
2010年3月
|
129,184
|
|
17,071
|
9,249
|
|
|
|
|
|
|
|
|
|
|
0.0%
|
13.21%
|
7.16%
|
|
|
|
|
|
|
|
|
0.00022588
|
0.00022588
|
2359人
|